Literature DB >> 91926

Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamide.

H Fowler, M Vulpe, G Marks, C Egolf, P C Dau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91926     DOI: 10.1016/s0140-6736(79)92423-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Chronic Inflammatory Demyelinating Polyneuropathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

2.  An update on the management of chronic inflammatory demyelinating polyneuropathy.

Authors:  Kenneth C Gorson
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

3.  Treatment of Guillain-Barré syndrome by plasma exchange.

Authors:  E Rumpl; U Mayr; F Gerstenbrand; J M Hackl; P Rosmanith; F Aichner
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Possible effectiveness of plasmapheresis on the neurological complications in a case of acute intermittent porphyria.

Authors:  D Sità; S Maurri; C Groppi; F Barontini
Journal:  Ital J Neurol Sci       Date:  1984-09

5.  Plasmapheresis in pediatric practice.

Authors:  A Nanu; S K Sood
Journal:  Indian J Pediatr       Date:  1983 Mar-Apr       Impact factor: 1.967

6.  Plasma exchange in Guillain-Barré syndrome.

Authors:  W F Durward; A K Burnett; R Watkins; J M Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

7.  Successful plasmapheresis in the Miller-Fisher syndrome.

Authors:  D N Maisey; S A Olczak
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

8.  Successful plasmapheresis in the Miller-Fisher syndrome.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

9.  Effects of plasmapheresis on the course of experimental allergic neuritis in rabbits.

Authors:  J H Antony; J D Pollard; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

Review 10.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.